Camber Capital Management LP - EPIRUS BIOPHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Camber Capital Management LP ownership history of EPIRUS BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$835,000
-83.2%
1,847,5000.0%0.04%
-86.3%
Q1 2016$4,970,000
-12.9%
1,847,5000.0%0.29%
-21.1%
Q4 2015$5,709,000
-30.1%
1,847,5000.0%0.37%
-47.3%
Q3 2015$8,166,000
-22.6%
1,847,5000.0%0.70%
-2.5%
Q2 2015$10,549,000
-36.2%
1,847,5000.0%0.72%
-39.2%
Q1 2015$16,535,0001,847,5001.18%
Other shareholders

There were no reported owners of EPIRUS BIOPHARMACEUTICALS IN in Q3 2023.

NameSharesValueWeighting ↓
View complete list of EPIRUS BIOPHARMACEUTICALS IN shareholders